Does use of intravascular ultrasound accelerate arteriopathy in heart transplant recipients?

Citation
R. Son et al., Does use of intravascular ultrasound accelerate arteriopathy in heart transplant recipients?, AM HEART J, 138(2), 1999, pp. 358-363
Citations number
22
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
AMERICAN HEART JOURNAL
ISSN journal
00028703 → ACNP
Volume
138
Issue
2
Year of publication
1999
Part
1
Pages
358 - 363
Database
ISI
SICI code
0002-8703(199908)138:2<358:DUOIUA>2.0.ZU;2-H
Abstract
Background intravascular ultrasound (IVUS) is a sensitive method for assess ing allograft vasculopathy in heart transplant recipients, but ii is not kn own whether this instrumentation traumatizes the transplanted arteries and affects progression of arteriopathy. Methods and Results Yearly coronary angiograms were obtained in 86 patients who underwent heart transplantation between January 1991 and May 1995. Pat ients were divided into 3 groups: (1) no IVUS performed after transplantati on (group 1, n = 47); (2) IVUS of the left anterior descending artery (LAD) performed only at year 1 (group 2, n = 13); and (3) IVUS of the LAD perfor med at both baseline (within 2 months after transplantation) and year 1 off er transplantation (group 3, n = 26). Coronary angiography measurements of lumen diameter were performed at 5 segments along the length of the LAD and left circumflex artery (LCX) from baseline through the second-year studies except in group 2, which did not receive a baseline angiogram; IVUS measur ements were obtained at 10 cross sections from each artery. Ai baseline, th ere was no significant difference in vessel diameter for either the LAD or the LCX artery between the IVUS (group 3) and no IVUS (group 1) groups. Wit hin each group,the lumen of both the LAD and LCX narrowed from baseline to year 1 (group 1: 3.3 +/- 0.6 mm to 2.8 +/- 0.5 mm in LAD, P =.001; 3.3 +/- 0.6 mm to 3.0 +/- 0.5 mm in LCX, P =.006; group 3: 3.5 +/- 0.7 mm to 3.1 +/ - 0.6 mm in LAD, P =.01; 3.1 +/- 0.6 mm to 2.8 +/- 0.5 mm in LCX, P = 0.07) , but there were no significant differences between the instrumented artery (LAD) and control artery (LCX) or further changes observed at year 2. Ther e were also no significant differences in the percent reductions at year 1 and year 2 between arteries or between groups. By IVUS, from baseline to ye ar 1 in group 3, the plaque cross-sectional area (CSA) increased (1.6 +/- 1 .9 to 2.3 +/- 1.7 mm(2), P <.0001), the lumen CSA decreased (12.7 +/- 3.7 t o 11.7 +/- 3.3 mm(2), P =.04), and the maximum lumen diameter decreased (4. 2 +/- 0.6 to 4.0 +/- 0.6 mm, P =.04). Conclusions The use of IVUS is not associated with acceleration of arteriop athy in heart transplantation recipients. luminal narrowing occurs predomin antly during the first year after transplantation. There was no significant change in lumen dimensions during the second year.